<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01313832</url>
  </required_header>
  <id_info>
    <org_study_id>H-1012-120-345</org_study_id>
    <nct_id>NCT01313832</nct_id>
  </id_info>
  <brief_title>The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intraoperative myocardial and pulmonary protection is important for better outcome after&#xD;
      cardiac surgery. Ischemic preconditioning is one of organ protective strategies against&#xD;
      ischemia-reperfusion injury by applying brief ischemia to the target organ before a&#xD;
      subsequent critical ischemia, and its effect has been confirmed. However, its clinical&#xD;
      application is not easy because ischemic insult may aggravate the function of vulnerable&#xD;
      organ.&#xD;
&#xD;
      On the other hand, remote ischemic preconditioning (RIPC) is another protective approach by&#xD;
      applying ischemia to other less vulnerable organ such as skeletal muscle before critical&#xD;
      ischemia-reperfusion injury to heart. The effect of RIPC has been well demonstrated in adults&#xD;
      and children. However, Little is known about the effect of remote ischemic precondition on&#xD;
      the pediatric myocardium to ischemia and reperfusion injury. The effect of RIPC on the&#xD;
      children remains to be further evaluated because the degree of ischemia-reperfusion injury is&#xD;
      different according to age, cardiac pathology and cyanosis. In addition, the previous report&#xD;
      on children dealt with a diverse range of congenital heart defects with a wide age range. The&#xD;
      purpose of this study was to evaluate the effect of RIPC on myocardial and pulmonary&#xD;
      protection in infants with pulmonary hypertension who need repair of simple ventricular&#xD;
      septal defect.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>December 2010</start_date>
  <completion_date type="Actual">April 2011</completion_date>
  <primary_completion_date type="Actual">April 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>troponin level</measure>
    <time_frame>within the 1 day after operation</time_frame>
    <description>troponin level will be checked 1, 6, 12 and 24 hours after operation. After making a graph for troponin-time, area under curve will be calculated.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">60</enrollment>
  <condition>Ventricular Septal Defect</condition>
  <condition>Pulmonary Hypertension</condition>
  <arm_group>
    <arm_group_label>remote ischemic preconditioning</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>remote ischemic preconditioning (RIPC)</intervention_name>
    <description>RIPC will be performed by 5-min cycles of lower limb ischemia reperfusion using blood pressure cuff</description>
    <arm_group_label>remote ischemic preconditioning</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  perimembranous or muscular outlet or muscular inlet ventricular septal defect&#xD;
&#xD;
          -  pulmonary hypertension (+)&#xD;
&#xD;
          -  infant (&lt;1 year)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subarterial ventricular defect&#xD;
&#xD;
          -  chromosomal defect&#xD;
&#xD;
          -  airway or parenchymal lung disease&#xD;
&#xD;
          -  blood disorder&#xD;
&#xD;
          -  anticipation of cardiac muscle resection&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Jin-Tae Kim</name>
      <address>
        <city>Seoul</city>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2012</verification_date>
  <study_first_submitted>March 10, 2011</study_first_submitted>
  <study_first_submitted_qc>March 10, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 14, 2011</study_first_posted>
  <last_update_submitted>February 1, 2012</last_update_submitted>
  <last_update_submitted_qc>February 1, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 2, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jin-Tae Kim</investigator_full_name>
    <investigator_title>assistant professor</investigator_title>
  </responsible_party>
  <keyword>ventricular septal defect</keyword>
  <keyword>remote ischemic preconditioning</keyword>
  <keyword>pulmonary hypertension</keyword>
  <keyword>infant with ventricular septal defect and pulmonary hypertension</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension, Pulmonary</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Heart Septal Defects</mesh_term>
    <mesh_term>Heart Septal Defects, Ventricular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

